Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 51 results:
Συντάκτης Τίτλος [ Τύπος] Έτος Φίλτρα: Keyword is Glaucoma, Open-Angle [Clear All Filters]
A 1-year study to compare the efficacy and safety of once-daily travoprost 0.004%/timolol 0.5% to once-daily latanoprost 0.005%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension..
Eur J Ophthalmol. 17(2), 183-90.
(2007).
(2017). 24-hour efficacy of travoprost/timolol BAK-free versus latanoprost/timolol fixed combinations in patients insufficiently controlled with latanoprost..
Adv Ther. 31(6), 592-603.
(2014). 24-hour intraocular pressure and blood pressure levels with latanoprost/timolol fixed combination versus timolol..
Curr Eye Res. 34(5), 369-77.
(2009). 24-hour intraocular pressure control with maximum medical therapy compared with surgery in patients with advanced open-angle glaucoma..
Ophthalmology. 113(5), 761-5.e1.
(2006). Aerobic exercise and intraocular pressure in normotensive and glaucoma patients..
BMC Ophthalmol. 9, 6.
(2009). Association of Cogan-Reese syndrome, exfoliation syndrome, and secondary open-angle glaucoma..
Eur J Ophthalmol. 22(1), 117-20.
(2012). Association of LOXL1 polymorphisms with pseudoexfoliation, glaucoma, intraocular pressure, and systemic diseases in a Greek population. The Thessaloniki eye study..
Invest Ophthalmol Vis Sci. 55(7), 4238-43.
(2014). Association of open-angle glaucoma with perfusion pressure status in the Thessaloniki Eye Study..
Am J Ophthalmol. 155(5), 843-51.
(2013). Association of POAG risk factors and the Thr377Met MYOC mutation in an isolated Greek population..
Invest Ophthalmol Vis Sci. 51(6), 3055-60.
(2010). An atypical presentation of lattice corneal dystrophy in a patient with juvenile glaucoma..
Eye (Lond). 20(8), 979-80.
(2006). Brimonidine 0.2% given two or three times daily versus timolol maleate 0.5% in primary open-angle glaucoma..
Am J Ophthalmol. 131(6), 729-33.
(2001). Characteristics of pseudoexfoliation in the Thessaloniki Eye Study..
J Glaucoma. 20(3), 160-6.
(2011). Circadian intraocular pressure and blood pressure reduction with timolol 0.5% solution and timogel 0.1% in patients with primary open-angle glaucoma..
J Clin Pharmacol. 52(10), 1552-7.
(2012). Common genetic determinants of intraocular pressure and primary open-angle glaucoma..
PLoS Genet. 8(5), e1002611.
(2012). A common variant mapping to CACNA1A is associated with susceptibility to exfoliation syndrome..
Nat Genet. 47(4), 387-92.
(2015). Common variants near ABCA1, AFAP1 and GMDS confer risk of primary open-angle glaucoma..
Nat Genet. 46(10), 1120-1125.
(2014). Comparison of 24-hour intraocular pressure reduction obtained with brinzolamide/timolol or brimonidine/timolol fixed-combination adjunctive to travoprost therapy..
J Ocul Pharmacol Ther. 29(7), 652-7.
(2013). Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on circadian intraocular pressure..
Ophthalmology. 114(12), 2244-51.
(2007). Compliance and viewpoint of glaucoma patients in Greece..
Eye (Lond). 14 Pt 5, 752-6.
(2000). Effect of trabeculectomy and canaloplasty on intra-ocular pressure modifications after postural changes in open-angle glaucoma..
Acta Ophthalmol. 92(6), e498-9.
(2014). Factors associated with undiagnosed open-angle glaucoma: the Thessaloniki Eye Study..
Am J Ophthalmol. 145(2), 327-335.
(2008). Genome-wide association analysis identifies TXNRD2, ATXN2 and FOXC1 as susceptibility loci for primary open-angle glaucoma..
Nat Genet. 48(2), 189-94.
(2016). Genome-wide association study of intraocular pressure identifies the GLCCI1/ICA1 region as a glaucoma susceptibility locus..
Hum Mol Genet. 22(22), 4653-60.
(2013). Helicobacter pylori infection as a risk factor for both primary open-angle glaucoma and pseudoexfoliative glaucoma in Thessaloniki Eye Study..
Am J Ophthalmol. 152(6), 1079-80; author reply 1080-1.
(2011).